Zacytuj

1. Kaito K, Kobayashi M, Katayama T, et al. Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol. 1998;103:297-303.10.1046/j.1365-2141.1998.01014.x9827895Search in Google Scholar

2. Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 2002;99:3129-3135.10.1182/blood.V99.9.312911964274Search in Google Scholar

3. Maciejewski JP, Selleri C. Evolution of clonal cytogenetic abnormalities in aplastic anemia. Leuk Lymphoma. 2004; 45:433-440.10.1080/1042819031000160236315160903Search in Google Scholar

4. Appelbaum FR, Barrall J, Storb R, et al. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol. 1987; 15:1134-1139Search in Google Scholar

5. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988; 69:413-418.10.1111/j.1365-2141.1988.tb02382.x3044440Search in Google Scholar

6. Sergej K, L. Jeffrey M, Patrick A, et al. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia. Cancer. 2007; 110(7):1520-1526.10.1002/cncr.2293517701956Search in Google Scholar

7. John M. Bennett, Attilio o, et al. Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach. Haematologica 2009; 94(2):264-26810.3324/haematol.13755263541419144661Search in Google Scholar

8. Seiji K, Akira O, et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood. 2002; 100(3):786-790.10.1182/blood.V100.3.786Search in Google Scholar

9. Phillip Scheinberg, Neal S. Young, How I treat acquired aplastic anemia. Blood. 2012 Aug 9; 120(6): 1185-119610.1182/blood-2011-12-274019341871522517900Search in Google Scholar

eISSN:
1582-196X
Język:
Angielski
Częstotliwość wydawania:
2 razy w roku
Dziedziny czasopisma:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology